462 related articles for article (PubMed ID: 33957166)
21. New insight into prurigo nodularis: Proadrenomedullin N-terminal 20 peptide mediates mouse mast cell activation via Mrgprb2.
Shao Y; Xiao Z; Jin Y; Zhu Y; Shen Y; Jin T; Tang H; Wang D
Skin Res Technol; 2024 Feb; 30(2):e13588. PubMed ID: 38284237
[TBL] [Abstract][Full Text] [Related]
22. MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants.
Chompunud Na Ayudhya C; Amponnawarat A; Roy S; Oskeritzian CA; Ali H
Cells; 2021 Jan; 10(1):. PubMed ID: 33467419
[TBL] [Abstract][Full Text] [Related]
23. Ligands and Signaling of Mas-Related G Protein-Coupled Receptor-X2 in Mast Cell Activation.
Mi YN; Ping NN; Cao YX
Rev Physiol Biochem Pharmacol; 2021; 179():139-188. PubMed ID: 33479839
[TBL] [Abstract][Full Text] [Related]
24. Mas-related G protein-coupled receptor X2 and its activators in dermatologic allergies.
Kühn H; Kolkhir P; Babina M; Düll M; Frischbutter S; Fok JS; Jiao Q; Metz M; Scheffel J; Wolf K; Kremer AE; Maurer M
J Allergy Clin Immunol; 2021 Feb; 147(2):456-469. PubMed ID: 33071069
[TBL] [Abstract][Full Text] [Related]
25. Lactic acid suppresses MRGPRX2 mediated mast cell responses.
Syed M; Kammala AK; Callahan B; Oskeritzian CA; Subramanian H
Cell Immunol; 2021 Oct; 368():104422. PubMed ID: 34399172
[TBL] [Abstract][Full Text] [Related]
26. All-trans-retinoic acid activated mast cells via Mas-related G-protein-coupled receptor-X2 in retinoid dermatitis.
Zheng Y; Che D; Peng B; Hao Y; Zhang X; He L; Geng S
Contact Dermatitis; 2019 Sep; 81(3):184-193. PubMed ID: 31006867
[TBL] [Abstract][Full Text] [Related]
27. Mas-Related G Protein-Coupled Receptor-X2 (MRGPRX2) in Drug Hypersensitivity Reactions.
Porebski G; Kwiecien K; Pawica M; Kwitniewski M
Front Immunol; 2018; 9():3027. PubMed ID: 30619367
[TBL] [Abstract][Full Text] [Related]
28. MrgprX2 regulates mast cell degranulation through PI3K/AKT and PLCγ signaling in pseudo-allergic reactions.
Zhang F; Hong F; Wang L; Fu R; Qi J; Yu B
Int Immunopharmacol; 2022 Jan; 102():108389. PubMed ID: 34920312
[TBL] [Abstract][Full Text] [Related]
29. DOCK2 regulates MRGPRX2/B2-mediated mast cell degranulation and drug-induced anaphylaxis.
Kunimura K; Akiyoshi S; Uruno T; Matsubara K; Sakata D; Morino K; Hirotani K; Fukui Y
J Allergy Clin Immunol; 2023 Jun; 151(6):1585-1594.e9. PubMed ID: 36804596
[TBL] [Abstract][Full Text] [Related]
30. MRGPRX2 sensing of cationic compounds-A bridge between nociception and skin diseases?
Corbière A; Loste A; Gaudenzio N
Exp Dermatol; 2021 Feb; 30(2):193-200. PubMed ID: 33107136
[TBL] [Abstract][Full Text] [Related]
31. Hydroquinone-induced skin irritant reaction could be achieved by activating mast cells via mas-related G protein-coupled receptor X2.
Zheng Y; Du X; Zhang L; Jia T; Zhang H; Peng B; Hao Y; Tong Z; Che D; Geng S
Exp Dermatol; 2023 Apr; 32(4):436-446. PubMed ID: 36463492
[TBL] [Abstract][Full Text] [Related]
32. Cytokines Stimulated by IL-33 in Human Skin Mast Cells: Involvement of NF-κB and p38 at Distinct Levels and Potent Co-Operation with FcεRI and MRGPRX2.
Franke K; Wang Z; Zuberbier T; Babina M
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808264
[TBL] [Abstract][Full Text] [Related]
33. GRK2 inhibitors, paroxetine and CCG258747, attenuate IgE-mediated anaphylaxis but activate mast cells
Thapaliya M; Amponnawarat A; Tesmer JJG; Ali H
Front Immunol; 2022; 13():1032497. PubMed ID: 36275707
[TBL] [Abstract][Full Text] [Related]
34. Mast cell degranulation via MRGPRX2 by isolated human albumin fragments.
Karhu T; Akiyama K; Vuolteenaho O; Bergmann U; Naito T; Tatemoto K; Herzig KH
Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2530-2534. PubMed ID: 28844982
[TBL] [Abstract][Full Text] [Related]
35. Endogenous protein and enzyme fragments induce immunoglobulin E-independent activation of mast cells via a G protein-coupled receptor, MRGPRX2.
Tatemoto K; Nozaki Y; Tsuda R; Kaneko S; Tomura K; Furuno M; Ogasawara H; Edamura K; Takagi H; Iwamura H; Noguchi M; Naito T
Scand J Immunol; 2018 May; 87(5):e12655. PubMed ID: 29484687
[TBL] [Abstract][Full Text] [Related]
36. MRGPRX2 antagonist GE1111 attenuated DNFB-induced atopic dermatitis in mice by reducing inflammatory cytokines and restoring skin integrity.
Wong TK; Choi YG; Li PH; Chow BKC; Kumar M
Front Immunol; 2024; 15():1406438. PubMed ID: 38817611
[TBL] [Abstract][Full Text] [Related]
37. Identification of inhibitory mechanisms in pseudo-allergy involving Mrgprb2/MRGPRX2-mediated mast cell activation.
Takamori A; Izawa K; Kaitani A; Ando T; Okamoto Y; Maehara A; Tanabe A; Nagamine M; Yamada H; Uchida S; Uchida K; Isobe M; Hatayama T; Watanabe D; Ando T; Ide T; Matsuzawa M; Maeda K; Nakano N; Tamura N; Ikeda K; Ebihara N; Shimizu T; Ogawa H; Okumura K; Kitaura J
J Allergy Clin Immunol; 2019 Mar; 143(3):1231-1235.e12. PubMed ID: 30414859
[No Abstract] [Full Text] [Related]
38. The Multifaceted Mas-Related G Protein-Coupled Receptor Member X2 in Allergic Diseases and Beyond.
Quan PL; Sabaté-Brescó M; Guo Y; Martín M; Gastaminza G
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922606
[TBL] [Abstract][Full Text] [Related]
39. Imiquimod-related dermatitis is mainly mediated by mast cell degranulation via Mas-related G-protein coupled receptor B2.
Hao Y; Peng B; Che D; Zheng Y; Kong S; Liu R; Shi J; Han H; Wang J; Cao J; Zhang Y; Gao J; He L; Geng S
Int Immunopharmacol; 2020 Apr; 81():106258. PubMed ID: 32044660
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic Potential of MRGPRX2 Inhibitors on Mast Cells.
Ogasawara H; Noguchi M
Cells; 2021 Oct; 10(11):. PubMed ID: 34831128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
